Lymphoma Clinical Trials in Shenyang
4 recruitingShenyang, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
AstraZeneca1,018 enrolled135 locationsNCT06549595
Recruiting
Phase 3
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Lymphoma
Hoffmann-La Roche182 enrolled75 locationsNCT06084936
Recruiting
Phase 1Phase 2
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
Diffuse Large B Cell Lymphoma
Dizal Pharmaceuticals150 enrolled16 locationsNCT07059650
Recruiting
Phase 3
A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Mantle Cell Lymphoma
InnoCare Pharma Inc.476 enrolled39 locationsNCT06363994